期刊
JOURNAL OF TRANSLATIONAL MEDICINE
卷 21, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s12967-023-04610-9
关键词
CRISPR; Oocyte; Embryo; Development; Human germline genome editing
CRISPR/Cas9, a highly versatile genome-editing tool, has been increasingly used in the reproduction of mammals. This review explores its principles and wide-ranging applications in oocyte and early embryo development, as well as its limitations and ethical concerns. Despite challenges, CRISPR/Cas9 technology undeniably represents a formidable tool for genome and epigenome manipulation within oocytes and early embryos.
CRISPR/Cas9, a highly versatile genome-editing tool, has garnered significant attention in recent years. Despite the unique characteristics of oocytes and early embryos compared to other cell types, this technology has been increasing used in mammalian reproduction. In this comprehensive review, we elucidate the fundamental principles of CRISPR/Cas9-related methodologies and explore their wide-ranging applications in deciphering molecular intricacies during oocyte and early embryo development as well as in addressing associated diseases. However, it is imperative to acknowledge the limitations inherent to these technologies, including the potential for off-target effects, as well as the ethical concerns surrounding the manipulation of human embryos. Thus, a judicious and thoughtful approach is warranted. Regardless of these challenges, CRISPR/Cas9 technology undeniably represents a formidable tool for genome and epigenome manipulation within oocytes and early embryos. Continuous refinements in this field are poised to fortify its future prospects and applications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据